ref_name,rx_name,iso_name,section,assay_name,potency_type,potency,cumulative_count,potency_upper_limit,potency_lower_limit,potency_unit,date_added
Kiso23b,Ensitrelvir,hCoV-19/USA/WI-UW-5250/2021,Table 1,Virus isolate,EC50,0.19,1,100,0.1,µM,2023-08-16
Kiso23b,Ensitrelvir,hCoV-19/USA/WI-UW-5250/2021+3CLpro:M49L,Table 1,Virus isolate,EC50,11.6,1,100,0.1,µM,2023-08-16
Kiso23b,Ensitrelvir,hCoV-19/USA/WI-UW-5250/2021+3CLpro:E166A,Table 1,Virus isolate,EC50,1.72,1,100,0.1,µM,2023-08-16
Kiso23b,Ensitrelvir,hCoV-19/USA/WI-UW-5250/2021+3CLpro:M49L+E166A,Table 1,Virus isolate,EC50,37.4,1,100,0.1,µM,2023-08-16
Kiso23b,Nirmatrelvir,hCoV-19/USA/WI-UW-5250/2021,Table 1,Virus isolate,EC50,8.63,1,100,0.1,µM,2023-08-16
Kiso23b,Nirmatrelvir,hCoV-19/USA/WI-UW-5250/2021+3CLpro:M49L,Table 1,Virus isolate,EC50,3.26,1,100,0.1,µM,2023-08-16
Kiso23b,Nirmatrelvir,hCoV-19/USA/WI-UW-5250/2021+3CLpro:E166A,Table 1,Virus isolate,EC50,11.2,1,100,0.1,µM,2023-08-16
Kiso23b,Nirmatrelvir,hCoV-19/USA/WI-UW-5250/2021+3CLpro:M49L+E166A,Table 1,Virus isolate,EC50,8.19,1,100,0.1,µM,2023-08-16
Kiso23b,Molnupiravir,hCoV-19/USA/WI-UW-5250/2021,Table 1,Virus isolate,EC50,3.31,1,100,0.1,µM,2023-08-16
Kiso23b,Molnupiravir,hCoV-19/USA/WI-UW-5250/2021+3CLpro:M49L,Table 1,Virus isolate,EC50,13.1,1,100,0.1,µM,2023-08-16
Kiso23b,Molnupiravir,hCoV-19/USA/WI-UW-5250/2021+3CLpro:E166A,Table 1,Virus isolate,EC50,13.5,1,100,0.1,µM,2023-08-16
Kiso23b,Molnupiravir,hCoV-19/USA/WI-UW-5250/2021+3CLpro:M49L+E166A,Table 1,Virus isolate,EC50,10.21,1,100,0.1,µM,2023-08-16
Kiso23b,Remdesivir,hCoV-19/USA/WI-UW-5250/2021,Table 1,Virus isolate,EC50,0.83,1,100,0.1,µM,2023-08-16
Kiso23b,Remdesivir,hCoV-19/USA/WI-UW-5250/2021+3CLpro:M49L,Table 1,Virus isolate,EC50,2.64,1,100,0.1,µM,2023-08-16
Kiso23b,Remdesivir,hCoV-19/USA/WI-UW-5250/2021+3CLpro:E166A,Table 1,Virus isolate,EC50,2.58,1,100,0.1,µM,2023-08-16
Kiso23b,Remdesivir,hCoV-19/USA/WI-UW-5250/2021+3CLpro:M49L+E166A,Table 1,Virus isolate,EC50,2.88,1,100,0.1,µM,2023-08-16
